ATE405249T1 - Körpergeruch verändernde biologisch aktive substanzen - Google Patents

Körpergeruch verändernde biologisch aktive substanzen

Info

Publication number
ATE405249T1
ATE405249T1 AT03725098T AT03725098T ATE405249T1 AT E405249 T1 ATE405249 T1 AT E405249T1 AT 03725098 T AT03725098 T AT 03725098T AT 03725098 T AT03725098 T AT 03725098T AT E405249 T1 ATE405249 T1 AT E405249T1
Authority
AT
Austria
Prior art keywords
changing
biologically active
active substances
body odor
mhc
Prior art date
Application number
AT03725098T
Other languages
English (en)
Inventor
Thomas Boehm
Manfred Milinski
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE405249T1 publication Critical patent/ATE405249T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Birds (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03725098T 2002-04-26 2003-04-25 Körpergeruch verändernde biologisch aktive substanzen ATE405249T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02009588A EP1358869A1 (de) 2002-04-26 2002-04-26 Körpergeruch verändernde biologisch aktive Substanzen

Publications (1)

Publication Number Publication Date
ATE405249T1 true ATE405249T1 (de) 2008-09-15

Family

ID=28799644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03725098T ATE405249T1 (de) 2002-04-26 2003-04-25 Körpergeruch verändernde biologisch aktive substanzen

Country Status (9)

Country Link
US (1) US20060039883A1 (de)
EP (2) EP1358869A1 (de)
JP (1) JP2005532299A (de)
AT (1) ATE405249T1 (de)
AU (1) AU2003227677A1 (de)
CA (1) CA2483750C (de)
DE (1) DE60323082D1 (de)
ES (1) ES2312774T3 (de)
WO (1) WO2003090705A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592910B2 (en) * 2005-09-28 2009-09-22 Social Fabric Corporation Matching system
EP2072529A1 (de) * 2007-12-21 2009-06-24 basisnote AG MHC-Schnellassay zur spezifischen Anpassung von Gerüchen
US20120315221A1 (en) * 2011-06-13 2012-12-13 Tuck Edward F Human sample matching system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929675A (en) * 1967-05-15 1975-12-30 Int Flavors & Fragrances Inc Novel products and processes
KR0148491B1 (ko) * 1991-05-30 1998-11-02 강진구 탈취제
WO1995028958A1 (en) * 1994-04-22 1995-11-02 Sloan-Kettering Institute For Cancer Research Induction of cytotoxic t lymphocytes (ctl) using antigenic peptides and a suitable adjuvant
EP0920328A1 (de) * 1996-08-23 1999-06-09 Massachusetts Institute Of Technology Allogene histokompabilitätkomplexe als mediatoren der zellzerstörung
DE10021579B4 (de) * 2000-04-27 2011-07-07 Coty B.V. Duftkomposition aus HLA-Molekülen

Also Published As

Publication number Publication date
CA2483750C (en) 2011-11-01
AU2003227677A1 (en) 2003-11-10
WO2003090705A1 (en) 2003-11-06
ES2312774T3 (es) 2009-03-01
EP1499284A1 (de) 2005-01-26
EP1499284B1 (de) 2008-08-20
CA2483750A1 (en) 2003-11-06
JP2005532299A (ja) 2005-10-27
EP1358869A1 (de) 2003-11-05
US20060039883A1 (en) 2006-02-23
DE60323082D1 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
BR0308090A (pt) conjugados de agentes citotóxicos ou terapêuticos e peptìdios biologicamente ativos
WO2005043967A8 (en) Z-axis assembly of medical device programmer
ATE504308T1 (de) Antimikrobielle kationische peptide und diese enthaltende formulierungen
BR0014652A (pt) Fabricação de conjugados de agente terapêutico-poliglutamato
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
DE60232660D1 (de) Humane dr4-antikörper und deren anwendungen
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
IL163900A (en) Antibody which binds to tpte for use in diagnosing, monitoring, preventing or treating cancer disease and pharmaceutical compositions comprising said antibody
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
EP1663201A4 (de) Verwendung von neuen 2-oxo-heterozyklischen verbindungen sowie diesen enthaltenden pharmazeutischen zubereitungen
EP1491210A4 (de) Therapeutisches arzneimittel unter verwendung von antikörper präsentierenden hohlen protein-nanoteilchen und hohle protein-nanoteilchen
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE50212280D1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
ATE405249T1 (de) Körpergeruch verändernde biologisch aktive substanzen
DE60330914D1 (de) Arzneimittel mit shikonin als wirkstoff
DK1636261T3 (da) Thrombopoietinproteiner med forbedrede egenskaber
ATE494307T1 (de) Neoplasma-spezifische antikörper und deren verwendungen
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
WO2004113386A3 (en) Modified hirudin proteins and t-cell epitopes in hirudin
WO2005087792A3 (en) Materials and methods relating to the treatment of glioblastomas
DE60327249D1 (de) Anthranilsäureamide und ihre pharmazeutische verwendung
DE502006004735D1 (de) Mittel zur behandlung von infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties